Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MEK1 antibody

MAP2K1 Reactivity: Human, Mouse, Rat, Xenopus laevis WB, IP Host: Mouse Monoclonal 4A5 unconjugated
Catalog No. ABIN1108123
  • Target See all MEK1 (MAP2K1) Antibodies
    MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))
    Reactivity
    • 353
    • 194
    • 193
    • 33
    • 30
    • 18
    • 12
    • 12
    • 12
    • 9
    • 7
    • 6
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Mouse, Rat, Xenopus laevis
    Host
    • 330
    • 20
    • 3
    • 2
    • 2
    Mouse
    Clonality
    • 283
    • 74
    Monoclonal
    Conjugate
    • 175
    • 25
    • 21
    • 16
    • 12
    • 12
    • 12
    • 12
    • 12
    • 12
    • 10
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 2
    • 2
    This MEK1 antibody is un-conjugated
    Application
    • 232
    • 124
    • 91
    • 68
    • 66
    • 47
    • 33
    • 29
    • 25
    • 15
    • 11
    • 10
    • 7
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP)
    Specificity
    This antibody reacts with MAPKK (MEK1).
    Cross-Reactivity (Details)
    Species reactivity (tested):Human, mouse, rat, xenopus
    Purification
    Protein A agarose
    Immunogen
    Recombinant Xenopus MAPKK
    Clone
    4A5
    Isotype
    IgG2a
    Top Product
    Discover our top product MAP2K1 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    PBS containing 50 % glycerol
    Preservative
    Azide free
    Handling Advice
    Avoid repeated freezing and thawing.
    Storage
    -20 °C
    Storage Comment
    Store (in aliquots) at -20 °C.
  • Target
    MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))
    Alternative Name
    MAP2K1 (MAP2K1 Products)
    Synonyms
    Mek1 antibody, CFC3 antibody, MAPKK1 antibody, MEK1 antibody, MKK1 antibody, PRKMK1 antibody, MEKK1 antibody, Prkmk1 antibody, mek-2 antibody, si:ch211-242m18.2 antibody, wu:fj56a12 antibody, wu:fj61b01 antibody, zgc:56557 antibody, ATMEK1 antibody, F20B18.180 antibody, F20B18_180 antibody, MAP kinase/ ERK kinase 1 antibody, MITOGEN ACTIVATED PROTEIN KINASE KINASE antibody, MITOGEN ACTIVATED PROTEIN KINASE KINASE 1 antibody, NMAPKK antibody, MEK antibody, mitogen activated protein kinase kinase 1 antibody, mitogen-activated protein kinase kinase 1 antibody, mitogen-activated protein kinase kinase 1 L homeolog antibody, MAP kinase/ ERK kinase 1 antibody, Map2k1 antibody, MAP2K1 antibody, map2k1.L antibody, map2k1 antibody, MEK1 antibody
    Background
    The MAP kinases mediate a wide range of cellular functions via a variety of signal transduction pathways in eukaryotic cells. The most studied mammalian MAP kinase pathway is the Ras-Raf-MEK-ERK pathway. The binding of GTP to Ras protein initiates a phosphorylation cascade through Raf-1 and MEK1/2 (MAPK kinase), which results in stimulation of the MAP kinases, ERK1/2. Upon stimulation, ERKs are known to phosphorylate a variety of cytosolic substrates and are also translocated into the nucleus where they initiate the transcription of immediate early genes. The Ras-Raf-MEK-ERK pathway is stimulated by various growth factors and extracellular stimuli and plays important roles in cell survival, differentiation and proliferation. The observation that MEK1/2 inhibitors potentiate the antitumor activity of various cytotoxic agents, including ara-C, cisplatin and paclitaxel, suggests a possible role for MEK1/2 inhibitors in the treatment of human malignancies.Synonyms: Dual specificity mitogen-activated protein kinase kinase 1, ERK activator kinase 1, MAP kinase kinase 1, MAPK/ERK kinase 1, MAPKK 1, MEK1, PRKMK1
    Gene ID
    5604
    NCBI Accession
    NP_002746
    UniProt
    Q02750
    Pathways
    MAPK Signaling, RTK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagy, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
You are here:
Support